Navigation Links
The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial
Date:12/3/2008

get="_new">ddarrah@ucsd.edu or the LLS Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET.

About Memgen, LLC

Memgen is a clinical stage biotechnology company with offices in Dallas and San Diego. Memgen was founded four years ago to develop non-toxic and targeted active immunotherapies for the treatment of cancers. Its lead product, ISF35, has demonstrated potent anti-leukemic activity as a single agent and is well-tolerated. ISF35 generates none of the immunosuppressive activities associated with standard cancer treatments.

For more information about Memgen, visit www.memgenbio.com.

About The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society(R), headquartered in White Plains, NY, with 68 chapters in the United States and Canada, is the world's largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. Since its founding in 1949, LLS has invested more than $600 million in research specifically targeting leukemia, lymphoma and myeloma. Last year alone, LLS made 5.1 million contacts with patients, caregivers and healthcare professionals.

For more information about blood cancer, visit www.LLS.org or call the LLS Information Resource Center (IRC), a call center staffed by master's level social workers, nurses and health educators who provide information, support and resources to patients and their families and caregivers. IRC information specialists are available at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET.

    LLS Contac
'/>"/>
SOURCE  The Leukemia & Lymphoma Society
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 

Related medicine technology :

1. Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH
2. St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse
3. Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium
4. Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study
5. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
6. The Leukemia & Lymphoma Society and Memgen Collaborate on CLL Clinical Trial
7. Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
8. Exelixis Presents Clinical Data Supporting the Safety and Initial Clinical Activity of XL228 in Chronic and Acute Leukemia
9. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
10. Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting
11. Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013 The Physician-Patient Alliance ... alarm fatigue. The need to urgently address this ... its Sentinel Event Alert #50 , "Medical device alarm safety ... database, between January 2008 and June 2012, there were 98 ... resulted in death (82%) , 13 resulted in permanent ...
(Date:6/19/2013)... June 19, 2013  Decision Resources, one of ... pharmaceutical and healthcare issues, finds that, for the ... U.S. and European rheumatologists cite a therapy,s induction ... most influences their prescribing decisions. Over 60 percent ... respectively, rank the percentage of patients achieving remission ...
(Date:6/19/2013)... SAN JOSE, Calif. , June 19, 2013 ... (NYSE: BDX ), a leading global medical technology ... X-20 Cell Analyzer , the latest in its line of ... X-20 Cell Analyzer delivers high-performance multicolor analysis with the most ... (76.2 X 73.7 cm) and a height of 30" (76.2 ...
Breaking Medicine Technology:Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3U.S. and European Rheumatologists Agree That a Therapy's Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis 2New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research 2
... global provider of professional services, announced today it has ... and apparel, to CI Capital Partners, a North American ... not disclosed.   (Logo: http://photos.prnewswire.com/prnh/20110907/PH63208LOGO) ... of public safety products to leading law enforcement, fire ...
... REDWOOD CITY, Calif., Oct. 3, 2011 OncoMed Pharmaceuticals, ... cancer stem cells, today announced that Jakob Dupont, M.D., ... at Genentech, a member of the Roche Group, has ... OncoMed, Dr. Dupont will be part of a global ...
Cached Medicine Technology:ARAMARK Agrees to Sell its Galls Business to CI Capital Partners 2ARAMARK Agrees to Sell its Galls Business to CI Capital Partners 3OncoMed Pharmaceuticals Names Dr. Jakob Dupont VP Clinical Research 2OncoMed Pharmaceuticals Names Dr. Jakob Dupont VP Clinical Research 3OncoMed Pharmaceuticals Names Dr. Jakob Dupont VP Clinical Research 4
(Date:6/19/2013)... St. Petersburg, FL (PRWEB) June 20, 2013 Everyone ... a fun, fast and inexpensive way to do so. It is ... a daily regime - only 5 minutes per day - to ... releases stress and improves general health. How? , Skin Brushing ... circulation , it aids the lymphatic system to drain ...
(Date:6/19/2013)... Go Classy Tours has the reputation for ... over 25 Years. These resorts, draw many clients from ... bars and nude hot tubs. Grand Lido Negril was ... SuperClubs re-branded the resort to a Breezes and dis-continued the ... the Resort fell off dramatically. "Groups just went to ...
(Date:6/19/2013)... Renick, WV (PRWEB) June 19, 2013 ... an individual used the sauna but the overall experience ... tended to be positive health-wise. , Mr Mouw, whose ... add to the Society’s statement by saying that the ... recently learned of a number of counterfeit imitations which ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Harris ... located at The Wailea Town Center providing vacation rental ... brokerage. Ken Harris, a licensed Hawaii Realtor since ... and is the principal broker. , Harris Hawaii ... the Wailea resort area offers spectacular scenery, pristine beaches, ...
(Date:6/19/2013)... 19, 2013 Brain not working? Functional ... explains why such seemingly minor brain problems as brain ... vital red flags. They indicate the brain may be ... (MS), Alzheimer’s, Parkinson’s, stroke, and other neurological diseases. ... 2013 by Elephant Press is now available online at ...
Breaking Medicine News(10 mins):Health News:A Fast and Fun Way to Better Skin Quality and Overall Health, says Sublime Beauty® 2Health News:The Former Breezes Resort is Re-Opened by Blue Diamond Resorts as the Original Grand Lido Negril Announced Go Classy Tours 2Health News:Health Benefits of Saunas Only Viable with Properly Constructed Models, Warns Manufacturer 2Health News:Harris Hawaii Realtor Group Opens New Office in Wailea, HI 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 3
... Illinois at Chicago College of Nursing has received a ... the early growth and development of premature infants who ... or minority status. , "Approximately half a million premature ... said Rosemary White-Traut, head of maternal-child nursing at UIC ...
... protein would let it thrive in upper airway, scientists say ... they,ve spotted a crucial step the deadly H5N1 bird flu ... , Since H5N1 first appeared in 1997, there have been ... Most of the human infections were the result of close ...
... WITH THE SEND FORMAT FOR DATA EXCHANGE AND ... ... PointCross announced today,the release of its PC-LDM(TM) Suite that ... (Standard,for Exchange of Non-Clinical Data), a CDISC (Clinical Data Interchange,Standards ...
... Oct. 4 With an estimated 50-70 million,sufferers, sleep ... in America according to the National Center on Sleep ... the number of people,suffering from sleep disorders grows, so ... Lunesta and Rozerem. In fact,according to CNNMoney.com, the market ...
... long-term respiratory trouble, researchers note , THURSDAY, Oct. ... researchers at Children,s Hospital Boston have found new ... dysplasia (BPD), a lung disease that affects premature ... predict, prevent or treat BPD, which can cause ...
... 4 Smooth talking Mitt,Romney is heading back ... support for,President Bush,s veto of legislation that would ... Hampshire. [Families USA, September 25,2007] Despite recent polls ... which would have provided health insurance to 10 ...
Cached Medicine News:Health News:$4 million nursing grant focuses on at-risk premature infants 2Health News:PointCross Releases Pre-Clinical Study Lifecycle and Data Management Suite (PC-LDM(TM)) For Multi-Party Environments 2Health News:Sleep Disorders: Waking Up to Reality 2Health News:Genes Give Clues to Newborn Lung Disease 2Health News:DNC: Romney an (S)CHIP Off the Bush Republican Block 2Health News:DNC: Romney an (S)CHIP Off the Bush Republican Block 3
Medpor 2/3 Orbit implants are designed to replace non load bearing bony structures in the orbital area....
... Orbital Rim implant can provide up to ... to be trimmed to meet the needs ... allows it to rest on the most ... flange allows easier positioning of the implant ...
Flattened points in vertical plane, straight shafts, cross action, round handle....
1.5 mm inner cutting edge....
Medicine Products: